au.\*:("6002-US-005 Study Group")
Results 1 to 1 of 1
Selection :
Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)LEWITT, Peter A; GUTTMAN, M; TETRUD, James W et al.Annals of neurology. 2008, Vol 63, Num 3, pp 295-302, issn 0364-5134, 8 p.Article
